The genetic confirmation of a suspected diagnosis of 'hereditary colorectal cancer' is of great importance for the medical care of affected families. However, many of the variants identified in the ...

The model has community clinicians offer take-home fecal immunochemical tests (FIT) for colorectal cancer alongside flu shots ...

The genetic confirmation of a suspected diagnosis of hereditary colorectal cancer is of great importance for the medical care ...

While cancer is the leading health issues across the world, an early diagnosis can prove to be a game-changer in saving a ...

The New York State Department of Health’s Clinical Laboratory Evaluation Program (CLEP) regulates and oversees laboratories ...

Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in ...

New research suggests patients with an average risk of colon cancer may only need to undergo a colonoscopy screening every 15 years instead of the recommended 10. Swedish researchers found that ...

With rising rates of colorectal cancers in younger people, UCSF experts tell you that getting screened for cancer may be as ...

The companies will initially develop an AI-based test to select patients with CDH17-expressing gastrointestinal cancers for Arbele's Phase I drug trial.

Created by Guardant Health, the blood test, known as Shield, was able to detect 83% of colorectal cancers in studies but only 13% of dangerous polyps. Colonoscopies find approximately 95% of these ...

Urteste Expands Development of Innovative Diagnostic Projects Gdansk, Poland - 26 SEPTEMBER 2024, 16:00 CET - Urteste S.A. (Warsaw Stock Exchange: URT), a biotechnology company specializing ...